We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$133B
1-Year Est. Return
43.5%
This Fund
S&P 500
This Quarter
Est. Return
+26.39%
1 Year Est. Return
+43.5%
3 Year Est. Return
+132.19%
5 Year Est. Return
+175.35%
10 Year Est. Return
+672.4%
AUM
$133B
AUM Growth
+$15.7B
(+13%)
Cap. Flow
-$1.75B
Cap. Flow
% of AUM
-1.32%
Top 10 Holdings %
Top 10 Hldgs %
30.35%
Holding
4,370
New
224
Increased
1,883
Reduced
1,827
Closed
182
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marvell Technology
MRVL
|
+$117M |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$117M |
| 3 |
SPCX
SpaceX
SPCX
|
+$100M |
| 4 |
P
Everpure Inc
P
|
+$67.3M |
| 5 |
Roku
ROKU
|
+$53M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$212M |
| 2 |
Microsoft
MSFT
|
+$156M |
| 3 |
Amazon
AMZN
|
+$142M |
| 4 |
Honeywell
HON
|
+$119M |
| 5 |
NVIDIA
NVDA
|
+$94.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.1% |
| 2 | Financials | 11.93% |
| 3 | Industrials | 10.35% |
| 4 | Consumer Discretionary | 9.64% |
| 5 | Healthcare | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GENB
2576
Generate Biomedicines
GENB
$1.94B
| $517K | ﹤0.01% |
+30,648
| New | +$418K |
|
|
CCRN
2577
DELISTED
Cross Country Healthcare
CCRN
| $516K | ﹤0.01% |
39,063
-1,529
| -4% | -$18.1K |
|
2578
Farmers & Merchants Bancorp
FMAO
$481M
| $515K | ﹤0.01% |
16,841
+1,301
| +8% | +$35.9K |
|
2579
Bowman Consulting
BWMN
$738M
| $515K | ﹤0.01% |
17,636
+401
| +2% | +$12.6K |
|
2580
Orthofix Medical
OFIX
$385M
| $514K | ﹤0.01% |
56,211
+1,287
| +2% | +$14.2K |
|
2581
Shutterstock
SSTK
$154M
| $513K | ﹤0.01% |
36,793
-36,517
| -50% | -$575K |
|
2582
Tejon Ranch
TRC
$445M
| $513K | ﹤0.01% |
27,429
+619
| +2% | +$12K |
|
2583
Village Super Market
VLGEA
$672M
| $512K | ﹤0.01% |
12,144
-5
| -0% | -$215 |
|
2584
Vitamin Cottage Natural Grocers
NGVC
$685M
| $512K | ﹤0.01% |
16,490
+1,015
| +7% | +$29.2K |
|
|
CTNM
2585
Contineum Therapeutics
CTNM
$473M
| $510K | ﹤0.01% |
+31,098
| New | +$408K |
|
|
DASTY
2586
DELISTED
DASSAULT SYSTEMES SA ADR
DASTY
| $509K | ﹤0.01% |
25,057
+1,230
| +5% | +$25K |
|
2587
Foster
FSTR
$394M
| $508K | ﹤0.01% |
11,247
+3,140
| +39% | +$117K |
|
2588
Amplify Energy
AMPY
$177M
| $507K | ﹤0.01% |
127,321
+125,545
| +7,069% | +$644K |
|
2589
One Stop Systems
OSS
$231M
| $507K | ﹤0.01% |
+27,871
| New | +$388K |
|
2590
Enanta Pharmaceuticals
ENTA
$346M
| $504K | ﹤0.01% |
34,571
+3,168
| +10% | +$42.6K |
|
2591
Ponce Financial Group
PDLB
$492M
| $503K | ﹤0.01% |
25,244
-1,891
| -7% | -$34.6K |
|
2592
Neuropace
NPCE
$483M
| $503K | ﹤0.01% |
31,664
+2,218
| +8% | +$35.7K |
|
2593
West Bancorporation
WTBA
$498M
| $502K | ﹤0.01% |
18,920
-155
| -0.8% | -$3.77K |
|
2594
Capital Bancorp
CBNK
$587M
| $498K | ﹤0.01% |
14,188
-636
| -4% | -$20.4K |
|
|
ITIC
2595
Investors Title Co
ITIC
$540M
| $498K | ﹤0.01% |
1,819
+10
| +0.6% | +$2.42K |
|
2596
Ibotta
IBTA
$827M
| $497K | ﹤0.01% |
14,552
-2,128
| -13% | -$71K |
|
2597
Titan International
TWI
$456M
| $497K | ﹤0.01% |
64,454
-78,191
| -55% | -$603K |
|
2598
Shattuck Labs
STTK
$609M
| $496K | ﹤0.01% |
+71,488
| New | +$446K |
|
2599
Contango Silver & Gold Inc
CTGO
$620M
| $496K | ﹤0.01% |
31,418
+17,848
| +132% | +$368K |
|
2600
Primis Financial Corp
FRST
$389M
| $494K | ﹤0.01% |
30,200
-497
| -2% | -$7.25K |
|
Similar funds
RhumbLine Advisers's Q2 2026 Portfolio in Review
As of Q2 2026, RhumbLine Advisers held 4,370 positions worth $133B, up 13% from $117B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
RhumbLine Advisers's Q2 2026 filing shows 224 new, 1,883 increased, 1,827 reduced and 182 closed positions. Its largest new stake was Honeywell Aerospace: 529,091 shares worth $117M. The largest sale was Apple, an estimated $212M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 31% a quarter earlier, followed by Financials and Industrials.
- RhumbLine Advisers's largest Q2 2026 buy was Honeywell Aerospace: 529,091 shares worth $117M.
- RhumbLine Advisers added most to Marvell Technology in Q2 2026, an estimated $117M increase.
- RhumbLine Advisers's biggest Q2 2026 reduction was Apple, cutting an estimated $212M.
- RhumbLine Advisers fully exited Coterra Energy in Q2 2026, selling an estimated $53.5M.
- RhumbLine Advisers's ten largest holdings make up 30% of its $133B portfolio in Q2 2026.
- RhumbLine Advisers opened 224 new positions and closed 182 in Q2 2026.
- RhumbLine Advisers's portfolio value rose 13% quarter-over-quarter to $133B.
Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.